mRNA vaccines show promise against pancreatic cancer

Can mRNA vaccines help in the fight against pancreatic cancer?
There is new hope in the fight against pancreatic cancer after early trials showed that personalized mRNA vaccines can target and reduce malignant tumors. NBC News medical contributor Dr. Kavita Patel reports on the vaccine’s success against pancreatic cancer,
New mRNA Vaccine Against World's Biggest Infectious Killer Shows Promise
A new mRNA vaccine against tuberculosis (TB) is showing favorable results in preclinical trials. With only one currently approved vaccine for TB – which recently surpassed COVID-19 to once again become the deadliest infectious disease on Earth – the findings are a great step forward in the quest to combat humanity’s ancient foe.
Trial shows promise of mRNA vaccines in treating pancreatic cancer
The phase 1 trial results, published Feb. 19 in Nature, evaluated the personalized mRNA neoantigen vaccine autogene cevumeran in combination with surgery, immunotherapy drug atezolizumab and chemotherapy in patients with pancreatic ductal adenocarcinoma.
mRNA vaccines show promise against pancreatic cancer in early trial
Personalized mRNA vaccines show promise as a pancreatic cancer treatment, according to a small, early stage trial published Wednesday.
New mRNA vaccine tested in mice has potential to help fight tuberculosis
A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials, as part of a successful collaboration between three leading Australian research institutions.
Vaccine shows promise for treating pancreatic cancer, study shows
A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study published in the journal Nature.
New mRNA vaccine shows promise against pancreatic cancer, may extend life by 10 years
In a significant development for pancreatic cancer treatment, a phase 1 clinical trial has highlighted the potential of personalized mRNA vaccines to treat the deadly disease. This research comes at a critical time,
Personal vaccine may reduce risk of pancreatic cancer returning after surgery, study finds
A personalized mRNA vaccine may reduce the risks of pancreatic cancer returning after surgery, according to a preliminary study published Wednesday in the journal Nature. Pancreatic cancer is one of the most aggressive cancers,
Proposed Idaho Senate bill would ban mRNA vaccines for a decade
Sen. Brandon Shippy brought the bill and presented it with a slate of out-of-state physicians, many of whom have been linked ...
Committee hears 2 hours of testimony on bill to ban mRNA vaccines for 10 years
Sen. Brandon Shippy brought the bill and presented it with a slate of out-of-state physicians, many of whom have been linked ...
The Daily Pennsylvanian1d
Here’s how Penn researchers are using mRNA technology to treat cancer, celiac disease
Penn researchers are developing new treatments using mRNA technology to combat a range of diseases, namely celiac disease ...
Circular mRNA produces 200 times more protein, enhancing precision therapy potential
Imagine a breakthrough in cancer treatment where only malignant cells are targeted, sparing healthy host cells; or patients ...
mRNA research explores new frontiers in celiac disease treatment
Jax Bari, an 11-year-old from Philadelphia, shows me a photo of himself. It's hard to look at; in it, he's sprawled out on ...
News Medical on MSN1d
New mRNA technique targets disease cells while sparing healthy ones Imag...
Imagine a breakthrough in cancer treatment where only malignant cells are targeted, sparing healthy host cells; or patients with abnormal protein synthesis are treated to produce a healthy protein.
Why Moderna (MRNA) Went Up on Tuesday?
We recently published a list of 10 Firms Kick Off Shortened Trading Week With Impressive Gains. In this article, we are going ...
How mRNA changes during the progression of atherosclerosis
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) and the Germans Trias i Pujol Research Institute (IGTP ...